The investment round saw the participation of Hudson Park Capital, PLH Business Ventures, ATX Seed Ventures, and several other industry veterans. CherryCircles’ software lets the pharma companies to capture development knowledge over time and handle risk across numerous dimensions with data. The US-based CherryCircle Software, …
IllumiCare’s Smart Ribbon technology is currently live across more than 120 hospitals in the U.S. OptimizeRx Corp., one of the most prominent provider of digital health messaging for the pharma industry, has declared that it has established a new partnership with IllumiCare. The agreement entails …
The JV, called CNNC Accuray (Tianjin) Medical Technology Co., Ltd. will be led by a seven-member Board of Directors, three members of which will be appointed by Accuray and four members by CIRC. Accuray Asia Ltd., a subsidiary of Accuray Incorporated, & CNNC High Energy …
Dr. Reddy’s Laboratories and its subsidiary – Promius Pharma, have reportedly announced the approval of TOSYMRA by the U.S. Food and Drug Administration (FDA). Prominently used for the treatment of acute migraine (with or without aura) in adults, TOSYMRA is seemingly the newest product to …
Renowned pharmaceuticals company Pharma major Dr Reddy’s Laboratories Ltd., has reportedly brought the Propofol Injectable Emulsion to the U.S. shores. Propofol, a therapeutic generic equivalent version of Diprivan (propofol) Injectable Emulsion, has been given the green signal by the U.S. Food and Drug Administration and …
NUI Galway’s research team has developed a wearable device for Parkinson’s patients to manage one of the most debilitating aspects of the disease. A team of researchers at the National University of Ireland (NUI) Galway, Ireland, has reportedly introduced a new wearable technology for easing …
Sanofi, a multinational pharmaceutical company based in France, has reportedly joined forces with GSK, the British pharmaceutical conglomerate, for the project FinnGen. As per reports, the project aims at collection of health data and biological samples from around 500,000 Finnish participants, which in turn, will …
The move sets UK as the only European country to approve TIV High Dose for the prevention of influenza flu specifically amongst senior citizens. The UK has reportedly granted marketing authorization to vaccine maker Sanofi Pasteur’s TIV (Trivalent Influenza Vaccine) High Dose, a vaccine prescribed …
Imatinib Mesylate is claimed to stop the growth of cancer cells and is prescribed for treating Leukemia and certain Gastro-Intestinal tumors. Renowned pharmaceutical and biotechnology company, Wockhardt, recently received the USFDA approval for an ANDA for 100 mg and 400 mg tablets of Imatinib Mesylate. …
